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Abstract
The transcriptional corepressor SMRT controls neuronal responsiveness of several transcription factors and can regulate
neuroprotective and neurogenic pathways. SMRT is a multi-domain protein that complexes with HDAC3 as well as being
capable of interactions with HDACs 1, 4, 5 and 7. We previously showed that in rat cortical neurons, nuclear localisation of
SMRT requires histone deacetylase activity: Inhibition of class I/II HDACs by treatment with trichostatin A (TSA) causes
redistribution of SMRT to the cytoplasm, and potentiates the activation of SMRT-repressed nuclear receptors. Here we have
sought to identify the HDAC(s) and region(s) of SMRT responsible for anchoring it in the nucleus under normal
circumstances and for mediating nuclear export following HDAC inhibition. We show that in rat cortical neurons SMRT
export can be triggered by treatment with the class I-preferring HDAC inhibitor valproate and the HDAC2/3-selective
inhibitor apicidin, and by HDAC3 knockdown, implicating HDAC3 activity as being required to maintain SMRT in the
nucleus. HDAC3 interaction with SMRT’s deacetylation activation domain (DAD) is known to be important for activation of
HDAC3 deacetylase function. Consistent with a role for HDAC3 activity in promoting SMRT nuclear localization, we found
that inactivation of SMRT’s DAD by deletion or point mutation triggered partial redistribution of SMRT to the cytoplasm. We
also investigated whether other regions of SMRT were involved in mediating nuclear export following HDAC inhibition. TSA-
and valproate-induced SMRT export was strongly impaired by deletion of its repression domain-4 (RD4). Furthermore, over-
expression of a region of SMRT containing the RD4 region suppressed TSA-induced export of full-length SMRT. Collectively
these data support a model whereby SMRT’s RD4 region can recruit factors capable of mediating nuclear export of SMRT,
but whose function and/or recruitment is suppressed by HDAC3 activity. Furthermore, they underline the fact that HDAC
inhibitors can cause reorganization and redistribution of corepressor complexes.
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Introduction
The precise regulation of gene transcription in the nervous
system is an integral part of processes that regulate neuronal
differentiation, development, long-term plasticity and the preven-
tion of pathological processes. This regulation is achieved in part
through a balance between the activity of transcriptional
coactivators and corepressors which in turn control gene
transcription when recruited to promoter elements via DNA-
binding transcription factors.
A key corepressor is Silencing Mediator of Retinoic acid and
Thyroid hormone receptors, SMRT (and its close relative N-CoR)
[1,2,3]. SMRT is a large multi-domain protein which binds to and
mediates repression effected by a number of transcription factors
including nuclear hormone receptors, C promoter Binding Factor
1 (CBF1), CCAAT/Enhancer Binding Protein C/EBP) ß, Serum
Response Factor (SRF), Nuclear Factor Erythroid 2 like-2 (Nrf2)
and MADS box transcription Enhancer Factor (MEF) 2 [1,2,4,5].
SMRT exists in a core complex containing Transducin-Beta-Like
(TBL) 1, TBL1 Receptor 1, G protein Pathway Suppressor 2
(GPS2) and histone deacetylase (HDAC) 3 [3,6,7,8,9,10].
Furthermore, SMRT recruits additional HDACs including the
class I HDAC, HDAC1 and the class II HDACs HDAC4,
HDAC5 and HDAC7 [1,2,3,11,12]. HDAC3 is likely to be the
primary enzyme responsible for the deacetylase activity in SMRT
complexes [3,13,14] which interacts with SMRT through SMRT’s
repression domain 4 (RD4) in the C terminus and its deacetylase
activating domain (DAD), on the N terminus [14]. SMRT does
not only act as a platform for HDAC3 recruitment, the DAD
domain functions as a cofactor for HDAC3 and is necessary and
sufficient for HDAC3 enzymatic activation [14].
In the central nervous system SMRT plays a critical role in
forebrain development and maintenance of the neural stem cell
state [15]. SMRT also can influence neuronal survival: it
specifically antagonizes PPARc coactivator 1a (PGC-1a)-mediated
antioxidant effects in neurons [16]. Thus, regulation of SMRT
activity can potentially have physiological consequences in the
central nervous system. SMRT activity can be regulated in
multiple ways. Classically, it gets displaced from nuclear receptors
by the presence of the cognate hormone, which causes a
conformational change in the receptor, creating the ‘ligand-form’
that causes SMRT to dissociate and a CREB Binding Protein/
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p300-containing coactivator complex to associate [17]. Other
signal pathways can also affect interaction of SMRT with
transcription factors, for instance, phosphorylation of SMRT by
MAPK MEK1 and MEKK1 inhibits interaction of SMRT with
nuclear receptors [18], while SMRT phosphorylation by Casein
Kinase II stabilizes the interaction [19]. SMRT stability is also
subject to dynamic control. Recruitment of the ubiquitin
machinery by TBL and TBLR mediates degradation of SMRT
[20], while phosphorylation by Cyclin Dependent Kinase 2 creates
a Pin binding site which also targets SMRT for degradation [21].
Nuclear export is another way by which different stimuli can
modify the function of transcription factors and cofactors,
including SMRT. Under normal conditions SMRT exists in
subnuclear domains colocalized with HDACs [2,22,23] and this
can be disrupted by several signal pathways, leading to SMRT
export from the nucleus. Several kinases such as MEK1, MEKK1,
AKT or Ikka phosphorylate SMRT, promoting nuclear export
[2,18,24,25]. In neurons, we showed that synaptic activity induces
nuclear export of SMRT via a mechanism involving nuclear Ca2+-
dependent CaM kinase activity as well as the Ras-ERK1/2
pathway [26]. The exact region of SMRT responsible for
mediating signal-dependent export has remained elusive: deletion
and truncation analysis revealed that no one domain is responsible
[16].
HDAC inhibition is emerging as an attractive therapy for a
number of neurodegenerative diseases as well as acute disorders
such as stroke [27–28]. While HDAC inhibition leads to histone
hyperacetylation and altered gene transcription as result of this,
many transcription factors and cofactors are also substrates for
HDACs. Interestingly, the localization of SMRT is itself
dependent on HDAC activity. Inhibition of HDAC activity
disrupts its localization within subnuclear domains and in neurons
we found that this leads to nuclear export [23,26]. As such, HDAC
inhibition not only inhibits enzyme activity, but in doing so causes
the relocalization of this key repressor. Thus, there is a strong
interdependence between SMRT and HDACs: SMRT is an
essential activating cofactor for HDAC3, while HDAC activity is
crucial for both the repressive function of SMRT and for its
nuclear localization. Here we have further investigated the basis of
SMRT export following HDAC inhibition, both in terms of the
specific HDAC involved, as well as the region(s) of SMRT
responsible for mediating export. We provide evidence that
SMRT nuclear localization specifically requires Class I HDAC
activity, likely to be HDAC3. Furthermore we show that full
nuclear localization requires the HDAC3-activating DAD of
SMRT. We also demonstrate that export following HDAC
inhibition is mediated by SMRT’s repression domain 4 (RD4)
region and is therefore mechanistically different from export
induced by synaptic activity.
Materials and Methods
Neuronal cultures and stimulations
All animal tissue was obtained by schedule 1 methods in
accordance with the Animals (Scientific Procedures) Act 1986 and
with the agreement of the University of Edinburgh Ethical Review
Committee for which a specific project licence is not required.
Cortical neurons from E21 Sprague Dawley rats were cultured as
described [26], using growth medium comprised of Neurobasal A
medium + B27 (Invitrogen), 1% rat serum, 1 mM glutamine.
Experiments were performed after a culturing period of 9–10 days
during which cortical neurons develop a rich network of processes,
express functional NMDA-type and AMPA/kainate-type gluta-
mate receptors, and form synaptic contacts [29,30]. Stimulations
were performed after transferring neurons into defined medium
lacking trophic support ‘‘TMo’’ [31]: 10% MEM (Invitrogen),
90% Salt-Glucose-Glycine (SGG) medium ([32]; SGG: 114 mM
NaCl, 0.219% NaHCO3, 5.292 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, 10 mMHEPES, 1 mM Glycine, 30 mMGlucose, 0.5 mM
sodium pyruvate, 0.1% Phenol Red; osmolarity 325 mosm/l,
hereafter TMo). Stimulations were initiated approximately 48 h
after transfection. HDAC inhibitors TSA (1 mM), Apicidin
(0.5 mM) and Valproate (5 mM) were added for 8 h.
Plasmids
GFP-SMRTa full length (GFP-SMRTFL) was a gift from
Martin Privalsky (UC Davis; [18]). Plasmids GFP-SMRT1–1523,
GFP-SMRTD(1018–1523), and myc-SMRT1025–1526 have been
described [16]. For the construction of GFP-SMRTD(1523–1854) a
MluI restriction site was inserted in GFP-SMRTFL at position
1523 by site-directed mutagenesis and this construct was cut with
MluI and BsrU36I blunt ended and re-ligated. The GFP-SMRT
lacking the deacetylase activating domain (DAD) (GFP-
SMRTD(305–547)) was made amplifying the whole GFP-SMRTFL
plasmid with the following primers: 59-ata cgc gtc tgg tca tag cgc
tgg ca -39 and 59-taa cgc gtg aca ctt ctg gcg agg aca ac-39 which
have a MluI restriction site, cut with MluI and re-ligate (adding to
the sequence two extra amino acids, Thr and Arg). To clone myc-
SMRT1025–1861 and myc-SMRT1517–1861 those regions were
amplified using the following primers: myc-SMRT1025–1861
forward 59-acg aat tca tgc cag tgc ctc ctg ccg aga aag ag-39,
reverse 59-cgc tct aga tca cag atc ttc ttc aga aat aag ttt ttg ttc cgg
gct gat ggg ctc cac ccc atc-39, myc-SMRT1517-1861 forward 5-acg
aat tca tgg acc acg ggg cac cct tca cca gt-39, reverse 59-cgc tct aga
tca cag atc ttc ttc aga aat aag ttt ttg ttc cga aga ggt gga ggt gga cct-
39. PCR products were cloned in EcoRI/XbaI sites of pEF1/V5-
His A expression vector (Invitrogen). Site-directed mutations were
performed with the QuikChange II XL site-directed mutagenesis
kit (Stratagene), following the manufacturer’s instructions. Phe-
nylalanine 451 within the DAD domain of SMRT was mutated to
Alanine (SMRTF451A) using the following oligonucleotide and its
reverse-complement: 59-cac cct aag aac gcc ggc ctg att gcc-39. An
in silico NES search [33] revealed a single rodent/human
conserved potential site IQELELRSL; aminoacids 1985 to
19993) in the C-terminus which contains the common LxxLxL
motif (where L is L/I/V/F/M). Leucines 1988 and 1990 were
mutated to Alanines (GFP-SMRTDLeu) with oligonucleotide 59-ctt
ttc cat cca gga agc gga agc ccg ttc tct ggg tta cc-39 and its reverse-
complement.
Transfections and immunofluorescence
Neurons were transfected using Lipofectamine 2000 (Promega)
following the manufacturers instructions. Transfections were
performed in TMo medium (see above) and carried out on
primary neurons plated in 24 well plates. For each well, 2.67 ml of
lipofectamine and 0.65 mg of plasmid DNA was used. siRNA
directed against HDAC3 (Santa Cruz sc-270161) or control
siRNA (Dharmacon’s control non-targeting siRNA #2 siRNA)
was used at 100 nM. Experiments were performed 48 h after
transfection (72 h for experiments involving siRNA). Immunoflu-
orescence was performed as described [34]. Anti-GFP antibody
(1:700; Invitrogen), anti-myc (1:1000; Santa Cruz) and anti-
HDAC3 (1:300, Genetex) were used and visualized using
biotinylated secondary antibody/cy2-conjugated streptavidin.
Nuclei were counter-stained with DAPI. Pictures of GFP-
SMRT-transfected neurons were taken on a Leica AF6000 LX
imaging system, with a DFC350 FX digital camera. The DFC350
FX digital camera is a monochrome camera, and so coloured
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images essentially involve taking a black and white image (using
the appropriate filter set) and applying a colour to the image after
capture. Subcellular distribution of SMRT was scored as being
either nuclear or having significant cytoplasmic localization
(cytoplasmic distribution in the cell body of a equal or greater
intensity than the nucleus). For each treatment, approximately
150–200 cells were analysed within 3–5 independent experiments.
Statistical analysis
Statistical testing involved a 2-tailed paired student T-test. For
any multiple comparisons within data sets we used a one-way
ANOVA followed by Fisher’s LSD post-hoc test.
Results
Inhibition of class I HDAC activity, likely HDAC3, is
sufficient to promote SMRT export
We previously reported that HDAC inhibition achieved by
treatment with TSA promotes nuclear export of SMRT [26],
prompting us to further investigate the mechanism and basis for
this export. We confirmed our previous observation that treatment
of cortical neurons with TSA caused the export of full length GFP-
SMRTa (GFP-SMRTFL, Fig. 1a). Many proteins are exported via
a CRM1-dependent association with a leucine-rich nuclear export
site (NES), although many are not [35]. Search for a classical
leucine-rich nuclear export site [33] revealed only one potential
site at position 1985 (QELELRSL), which when mutated to
QEAEARSL (GFP-SMRTDLeu), had no effect on TSA-induced
export (Fig. 1a), or indeed, export by synaptic activity (data not
shown). Moreover, TSA-induced SMRT export was found to be
insensitive to leptomycin B (Fig. 1a), and thus joins a lengthening
list of proteins (that include many nuclear hormone receptors)
whose export is independent of the CRM1/leucine-rich NES
pathway.
SMRT has been reported to interact with the class I HDACs
HDAC1 and HDAC3, and the class II HDACs HDAC4, HDAC5
and HDAC7 [1,2,3,6,11,12]. Since TSA inhibits both Class I and
II HDACs, we investigated whether TSA-induced export is due to
Class I or Class II HDAC inhibition. We transfected neurons with
a vector encoding GFP-SMRTFL and after 48 h treated them with
sodium valproate (VPA), a Class I-specific HDAC inhibitor [36].
VPA treatment was sufficient to induce GFP-SMRT export
(Fig. 1b,c). We also found that treatment of neurons with apicidin,
a HDAC inhibitor selective for Class I HDAC members HDAC2
and HDAC3 [36], was sufficient to promote GFP-SMRT export
(Fig. 1b,c). Since HDAC3, but not HDAC2, interacts with SMRT
and is a central part of SMRT and N-CoR corepressor complexes
[3,37], these pharmacological inhibition experiments suggest that
a key mediator of TSA-induced SMRT export is the inhibition of
HDAC3 activity. To test this directly we knocked down HDAC3
expression using siRNA (Fig. 1d). HDAC3 knockdown caused
significant redistribution of SMRT to the cytoplasm, compared to
a control siRNA (Fig. 1e). Taken together, these data indicate a
role for HDAC3 activity in maintaining SMRT nuclear
localization.
Deletion or mutation of SMRT’s DAD partly mimics the
effect of HDAC inhibition
HDAC3 forms a core complex with SMRT and is absolutely
required for its function as a corepressor [6,37]. HDAC3 has been
reported to interact with SMRT at least two different regions,
including the RD4 region [2] and also a region in the N-terminus
referred to as the deacetylase activation domain (DAD).
Interaction of HDAC3 with the DAD is both necessary and
sufficient to activate the deacetylase activity of HDAC3, which is
otherwise inactive [14]. As such, HDAC3 activity is restricted to
complexes with SMRT or its close relative N-CoR. We therefore
predicted that deletion of a portion of SMRT containing the DAD
could, by inactivating HDAC3, mimic the effect of TSA treatment
in promoting SMRT export. We deleted amino acids 305–547
within the context of full length 2472 amino-acid SMRT (GFP-
SMRTD(305–547)), a schematic illustration of this and all SMRT
constructs used in this study is shown in Fig. 2a. GFP-SMRTD(305–547)
exhibited increased cytoplasmic localization compared to GFP-
SMRTFL (Fig. 2b). The effect of DAD deletion in causing cytoplasmic
redistribution was non-additive to the effect of TSA: TSA treatment of
GFP-SMRTD(305–547)-expressing neurons caused a small additional
export, but the total level of cytoplasmic SMRTwas the same in TSA-
treated neurons expressing GFP-SMRTFL as GFP-SMRTD(305–547).
Given that deletion of DAD blocks SMRT-associated HDAC3
activity [14], this indicates that TSA is acting (at least in part) by
blocking SMRT-associated HDAC3 activity. Since point mutation of
the DAD at several locations can also inhibit DAD function and
SMRT-associated HDAC3 activity [14], we created a DAD-
inactivating mutant (GFP-SMRTF451A, [14]). As with GFP-
SMRTD(305–547), GFP-SMRTF451A exhibited increased cytoplasmic
localization compared to GFP-SMRTFL (Fig. 2c), further evidence
that DAD-induced HDAC3 activity is important for SMRT nuclear
localization. Note though that deletion of the DAD, or its mutation
did not completely mimic the effect of TSA treatment, potentially
indicating that HDAC activity other than HDAC3 activated by the
DAD may contribute to SMRT nuclear localization. Alternatively,
since SMRT can homodimerize [38], dimerization between
SMRTD(305–547) or SMRTF451A and endogenous SMRT could result
in recruitment of active HDAC3 to the dimer.
The RD4 region is necessary to mediate SMRT export
following HDAC inhibition
We next sought to identify the region of SMRT responsible for
mediating nuclear export following HDAC inhibition. We found
that truncating the C-terminus of SMRT from position 1524
onwards (GFP-SMRT1–1523) had no effect on basal nuclear
localization of SMRT but completely abolished export following
treatment with TSA, or VPA (Fig. 3a–c). Furthermore, the
deletion of SMRT’s RD4 region achieved by removing amino
acids 1523–1854 (GFP-SMRTD(1523–1854)) also largely abolished
export following treatment with TSA or VPA, without affecting
basal nuclear localization (Fig. 3a–c). This indicated that the RD4
region may recruit factor(s) responsible for mediating CRM1-
independent SMRT export upon HDAC inhibition.
If this were indeed the case, we predicted that over-expression of
the RD4 region within the nucleus would compete with SMRT for
these hypothetical factors and inhibit TSA-induced export of GFP-
SMRTFL. We first expressed a portion of SMRT containing the
RD4 region (SMRT1517–1861) but found it to be exclusively
cytoplasmic (data not shown), consistent with our recent
observations that sequences N-terminal of position 1523 are
required for nuclear localization of SMRT [16]. We therefore
expressed a larger portion of SMRT (SMRT1025–1861), still
including the RD4 region but with additional N-terminal sequence
within the RD3 region which, upon expression, revealed nuclear
localization (Fig. 4a lower). We therefore investigated the effect of
expressing SMRT1025–1861 on TSA-induced export of GFP-
SMRTFL. We found that co-expression of SMRT1025–1861
inhibited TSA-induced export of GFP-SMRTFL (Fig. 4a, upper).
To determine whether this effect could be attributed directly to the
RD4 region (SMRT1523–1861), we investigated the effect of
expressing SMRT1025–1523, the region N-terminal of the RD4
Investigating SMRT Export by HDAC Inhibition
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region (containing RD3) that we added in order to confer nuclear
localization. Expression of SMRT1025–1523, which is localized to
the nucleus ([16] and Fig. 4a lower), failed to inhibit TSA-induced
export of SMRTFL (Fig. 4a, upper), strongly indicating that the
inhibitory effect of SMRT1025–1861 is due to the presence of the
RD4 region and not the RD3 region. Thus, over-expression of
RD4 region interferes with TSA-induced SMRTFL export,
consistent with the deletion studies and further implicating this
domain as being required for interaction with the SMRT export
machinery.
Given that deletion of a region of SMRT containing the DAD
(SMRTD(305–547)) results in partial redistribution of SMRT to the
cytoplasm, we reasoned that co-expression of SMRT1025–1861, by
interfering with the export process, might reduce the cytoplasmic
localization of SMRTD(305–547). This was indeed found to be the
case: the proportion of neurons with cytoplasmic SMRTD(305–547)
was substantially reduced by co-expression of SMRT1025–1861
(Fig. 4b). In contrast expression of SMRT1025–1523 had no effect
(data not shown). Thus, over-expressing the SMRT RD4 region
partially reversed the effect of deleting the DAD with respect to
SMRT nuclear localization.
Discussion
Here we have presented data which suggests that class I HDAC
activity is necessary for nuclear retention of the corepressor SMRT
in neurons. HDAC3, a known component of the core SMRT
complex, is likely to be an important HDAC responsible for
SMRT nuclear retention as suggested by the fact that the specific
HDAC2/3 inhibitor Apicidin promotes SMRT nuclear export, as
does HDAC3 knock-down, as well as deletion and mutation of the
HDAC3-activating DAD region. Additionally, deletion and over-
expression studies implicate the RD4 region as a key mediator of
HDAC inhibitor-induced SMRT export.
Lysine acetylation controls protein interactions and
subcellular localisation
In recent years lysine acetylation of non-histone proteins has
emerged as an important post-translational protein modification
regulating function in different ways including protein interactions
and subcellular localization [39]. Global acetylome analysis in
three different human cell lines identified 3600 lysine acetylation
sites on 1750 proteins, 17 of those proteins have a function in
Figure 1. Inhibition of class I HDAC and knockdown of HDAC3 is sufficient to promote SMRT export. A) GFP-SMRTFL export is insensitive
to Leptomycin B and to mutation of a leucine-rich potential nuclear export sequence. Neurons were transfected with plasmids encoding GFP-SMRTFL
or GFP-SMRTDLeu and treated, where indicated with Leptomycin B (20 ng/ml) for 1 h prior to treatment with TSA. Note that although redistribution
was observed after 1–2 h treatment with TSA and other HDAC inhibitors, the effect observed was greater after 6–8 h and so all data presented in this
manuscript relates to treatment with the indicated drugs for this time. *p,0.05 (n = 4). B) Neurons were transfected with plasmids encoding GFP-
SMRTFL and 48 h after transfection the neurons were treated with TSA, VPA or Apicidin and the cellular localization of GFP-SMRTFL was analyzed.
*p,0.05 (n = 3). C) Examples of the cellular localization of GFP-SMRTFL after treatments with the indicated HDAC inhibitors. Scale bar is 20 mm here
and throughout the manuscript. D) Example pictures to demonstrate the efficacy of HDAC3-directed siRNA in knocking down endogenous HDAC3
expression in rat cortical neurons. Neurons were transfected with the siRNAs as indicated, plus peGFP to identify transfected cells. After 72 h, cells
were fixed and HDAC3 expression analysed by immunofluorescence. White arrows point to transfected neurons. E) HDAC3 siRNA causes
redistribution of SMRT to the cytoplasm. Neurons were transfected with plasmids encoding GFP-SMRTFL plus siRNA as indicated. SMRT localization
was studied 72 h post-transfection. *p,0.05 (n = 5).
doi:10.1371/journal.pone.0021056.g001
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Figure 2. Deletion of SMRT’s HDAC3-activating domain partly mimics and occludes the effect of HDAC inhibition. A) Schematic
illustrating the SMRT deletion constructs generated and used in this paper. B) Analysis of the cellular localization of GFP-SMRTFL or GFP-SMRTD(305–547)
in transfected neurons untreated or treated with TSA. *p,0.05 (n = 4). #p,0.05 comparing control and TSA-treated conditions for each SMRT
construct. C) Analysis of the cellular location of GFP-SMRTFL compared to the basal localization of GFP-SMRTF451A. *p,0.05 (n = 5).
doi:10.1371/journal.pone.0021056.g002
Figure 3. The RD4 region is necessary to mediate SMRT export following HDAC inhibition. Analysis of the cellular localization of the
indicated GFP-SMRT fusions, transfected into neurons and treated with TSA (A) or VPA (B). *p,0.05 (n = 3). #p,0.05 comparing control and drug-
treated conditions for each SMRT construct. C) Example pictures from (A). Scale bar 20 mm.
doi:10.1371/journal.pone.0021056.g003
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nuclear transport, suggesting that this process is sensitive to the
cells acetylase-deacetylase balance [40]. Furthermore, many
transcription factors have been shown to move between the
cytoplasm and nucleus in a manner dependent on their direct
acetylation.
For example, p53 acetylation by p300 mediates its nuclear export
[41], while SIRT1/2-mediated deacetylation promotes FOXO1’s
nuclear localization [42,43]. Acetylation of Poly(A)-polymerase
disrupts its interaction with Importin-a/b complex resulting in
cytosolic accumulation [44]. Several transcription factors involved
in development exhibit acetylation-sensitive subcellular localization.
In embryonic stem cells, acetylation of Sox2, a factor important for
maintenance of pluripotency, induces its nuclear export [45].
Acetylation of SRY, (crucial for testis organogenesis) by p300
augments its nuclear import, while its deacetylation by HDAC3
induces a partial cytoplasmic distribution [46].
Of note, SMRT is also involved in development, particularly
neurogenesis where it is needed to provide fidelity to both Notch-
and retinoic acid-dependent aspects of forebrain development
and neurogenesis [15]. Despite our investigations into the role of
acetylation in SMRT export, it remains unclear whether SMRT
redistribution is due to direct changes in its own acetylation.
Human SMRT was reported to have least three acetylatable
lysine residues at positions 959, 1794 and 2036 [40]. Given the
sensitivity of SMRT localization to HDAC inhibition we mutated
these residues to non acetylatable arginine residues. However,
mutation of these sites alone or in triple combination did not
prevent the TSA-mediated SMRT export (data not shown).
Thus, it remains unclear whether HDAC inhibition-mediated
SMRT export is a consequence of a direct modification in the
acetylation status of SMRT or a modification in its associated
proteins in the SMRT complex, or indeed in proteins involved in
SMRT export.
HDAC3 is important for full nuclear localization of SMRT
Although other HDACs may contribute, data presented in this
study indicates that HDAC3 is likely to be an important
deacetylase responsible for retaining SMRT in the nucleus.
HDAC3 absolutely requires SMRT’s DAD domain for HDAC
activity and thus acts as a coenzyme of HDAC3 [14]. In our study,
SMRT mutants either lacking the DAD domain (GFP-
SMRTD(305–547)), or with a DAD-inactivating mutation (GFP-
SMRTF451A), partially mimicked the effect of HDAC inhibitors in
promoting cytoplasmic localization, as did HDAC3 knockdown.
Nonetheless, this GFP-SMRTD(305–547) was further exported in
presence of HDAC inhibitors which suggest that HDACs other
than HDAC3 may contribute to SMRT nuclear localisation.
Alternatively, since SMRT can homodimerize [38], dimerization
between SMRT lacking the DAD with wild-type SMRT may
recruit active HDAC3 to the complex, thus explaining the partial
effect of DAD deletion. As stated earlier, disruption to the DAD of
SMRT or N-CoR essentially abolished both HDAC3 activity and
corepressor function [14,47]. The fact that this also causes some
cytoplasmic redistribution of SMRT (this study) raises the
possibility that elimination of repressor function could be due in
part to SMRT relocalization to the cytoplasm. While this is a
possibility, the effect of DAD disruption on SMRT corepressor
function is more dramatic than its effect on nuclear localization
([14] and this study), indicating that even nuclear-localized SMRT
is inactive if it lacks a functional DAD. Thus the conclusions of the
earlier studies by Lazar and coworkers are not in question.
A model to explain histone deacetylase-dependent SMRT
localization
In contrast to deletion/mutation of the DAD, which caused
basal cytoplasmic redistribution, deletion of the RD4 region had
Figure 4. Over-expression of the RD4 region of SMRT inhibits HDAC inhibition-mediated SMRT export. A) Upper: Over-expression of
RD4 inhibits TSA-mediated nuclear export of SMRT. Neurons were transfected with GFP-SMRTFL plus an expression vector encoding the amino-acids
1025–1526 (RD3) or 1025–1861 (RD3–4) of SMRT or a control plasmid (encoding ß-globin). After 48 h neurons were treated with TSA and the
subcellular localization of GFP-SMRTFL was analyzed. *p,0.05 (n = 4). Lower: Example pictures to illustrate the nuclear localization of SMRT1025–1526
and SMRT1025–1861. Neurons were transfected with plasmids encoding myc-tagged SMRT1025–1526 or SMRT1025–1861. After 48 h the localization of these
portions of SMRT was analysed by immunofluorescence using an anti-myc antibody. Arrows point to a transfected cell in each case. B) Over-
expression of the RD4 region partially reverses the cytoplasmic redistribution of SMRT caused by deletion of the DAD. Neurons were co-transfected
with GFP-SMRTFL or SMRTD(305–547) with an expression vector encoding the amino acids 1025–1861 of SMRT or a control plasmid (encoding ß-globin)
as indicated. After 48 h the cellular localization of SMRT and SMRTD(305–547) was analyzed. *p,0.05 (n = 3).
doi:10.1371/journal.pone.0021056.g004
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no effect on basal localization but strongly reduced export
triggered by HDAC inhibition. Thus the HDAC3-suppressed
export process acts on SMRT in a manner that requires the RD4
region. This could be explained by two potential models. Export
machinery could be recruited to the RD4 region of SMRT but in
a manner that requires acetylation within this region, an event that
is ordinarily suppressed by HDAC3. As a variation on this, the
export machinery recruited to the RD4 region of SMRT could
itself be directly or indirectly inhibited by HDAC3 activity.
Distinguishing between these models forms part of ongoing
investigations. Regardless of this, it is clear that SMRT export
triggered by HDAC inhibition is mechanistically distinct from
another form of signal-induced SMRT export-that induced by
synaptic activity [16,26]. In contrast to results presented here,
deletion of the RD4 region has no effect on SMRT export
triggered by synaptic activity [16].
Inhibition of HDACs as a neuroprotective strategy
In recent years the use of HDAC inhibitors has emerged as a
potential therapy against cancer and neurodegenerative disorders,
including Parkinson’s, Alzheimer’s, Huntington’s diseases and
amyotrophic lateral sclerosis. Beneficial effects of HDAC inhibi-
tion have been found in models of the above diseases, as well as in
acute trauma such as stroke [27–28]. Given the growing number
of non-histone HDAC targets been discovered, old assumptions
based on mechanisms solely surrounding histone acetylation status
are being challenged [48]. Moreover, the pleiotropic effects of
HDAC inhibition and neurotoxicity of sustained strong inhibition
raise the question as to their suitability for treating chronic
neurodegenerative disease [49], particularly given the documented
adverse side-effects of HDAC inhibitors after short-term therapy
in cancer patients [50]. In order to find more selective and
tolerable inhibitors of HDAC effects, future strategies may be to
use peptides or molecules designed to disrupt interactions between
HDACs and key targets relevant to neuroprotection. We recently
demonstrated a neuroprotective consequence of promoting
SMRT export, since when nuclear it is able to antagonize the
neuroprotective, antioxidant effects of the transcriptional coacti-
vator PGC-1a [16]. Further investigation into the mechanism of
SMRT export may point to strategies aimed at controlling
SMRT-mediated repression.
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